Form 4 Tracker
Bicara Therapeutics Inc.
BCAX

24 insider filings · Latest: May 8, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 9, 2025Oct 9 8:08 PMRaben David
Proposed Sale
22,000$18.45$405.9K

View →

Oct 8, 2025Oct 8 8:04 PMHyep Ivan
Proposed Sale
5,627$18.17$102.2K

View →

Oct 7, 2025Oct 7 8:20 PMHyep Ivan
Proposed Sale
18,244$18.00$328.4K

View →

Oct 7, 2025Oct 7 8:07 PMCohlhepp Ryan
Proposed Sale
10,900$18.00$196.2K

View →

Oct 6, 2025Oct 6 8:36 PMCohlhepp Ryan
Proposed Sale
39,600$18.06$715.0K

View →

Oct 6, 2025Oct 6 8:07 PMHyep Ivan
Proposed Sale
6,514$17.04$111.0K

View →

Sep 29, 2025Sep 29 8:38 PMLARA MEISNER
Proposed Sale
33,807$11.71$395.9K

View →

Jun 16, 2025Jun 16 8:29 PMLARA S. MEISNER
Proposed Sale
31,658$10.84$343.2K

View →

Mar 14, 2025Mar 14 8:21 PMLARA S. MEISNER
Proposed Sale
79,146$13.35$1.1M

View →

← Previous

Page 4 of 4

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 3, 2026Mar 6 12:06 AMDavid RabenChief Medical Officer
Option Exercise
200$3.7969,213(D)

View →

Feb 26, 2026Mar 2 9:22 PMRA CAPITAL MANAGEMENT, L.P.Director, 10% Owner
Purchase
2,200,000$0.00012,200,000(I)

View →

Feb 25, 2026Feb 27 9:13 PMRyan CohlheppDirector, President and COO
Option Exercise
3,108$3.79138,226(D)

View →

Feb 2, 2026Feb 4 9:38 PMRyan CohlheppDirector, President and COO
Grant/Award
300,000$16.76300,000(D)

View →

Feb 2, 2026Feb 4 9:37 PMClaire MazumdarDirector, Chief Executive Officer
Grant/Award
450,000$16.76450,000(D)

View →

Feb 2, 2026Feb 4 9:36 PMDavid RabenChief Medical Officer
Grant/Award
100,000$16.76100,000(D)

View →

Feb 2, 2026Feb 4 9:35 PMIvan HyepChief Financial Officer
Grant/Award
125,000$16.76125,000(D)

View →

Feb 2, 2026Feb 4 9:34 PMLara MeisnerChief Legal Officer
Grant/Award
90,000$16.7690,000(D)

View →

Jan 22, 2026Jan 26 9:33 PMIvan HyepChief Financial Officer
Option Exercise
1,882$3.7965,462(D)

View →

← Previous

Page 2 of 2